• br The release behavior of CSs from the

  2022-05-19

  

  The release behavior of CSs from the CDEAC hydrogel upon adding the ClO− (10 nM) was further studied. MCF-7 Cisplatin did not show ob-vious toxicity when cultured with ClO−/SCN−(Supplementary Fig. S21). As shown in Fig. 6A, the morphology of the released CSs were identical to that of the prerelea

• br A cell transfection br A cells were

  2022-05-18

  

  A375 cell transfection A375 cells were seeded at the density of 0.15 million per well in 6-well plates. At 24 h after seeding, transfection was performed using 2 mg plasmid and 4 mL of X-treme GENE HP reagent (06 366 236 001, Roche) per well with the standard protocol provided by the manufactur

• br after completing definitive RT These findings are reflected

  2022-05-18

  

   after completing definitive RT. These findings are reflected in various guidelines, which currently recommend against the use of 18FDG-PET/CT for routine surveillance imaging after curative-intent interventions in NSCLC. Approximately 15% to 30% of stage III NSCLC patients will have intracra

• br Supported in part by the National Science Fund of

  2022-05-18

  

  Supported in part by the National Science Fund of China (11571284). ∗ Corresponding author. E-mail address: wendi@swu.edu.cn (W. Wang). the level of PSA. The treatment is activated when the PSA level is above a certain value L1 and it turns off (patient takes a vacation period) when the PSA

• br When specifically examining the covariates used in the modeling

  2022-05-15

  

  When specifically examining the covariates used in the modeling, our results suggested that Ionomycin and education were the stronger corre-lates of satisfaction across domains. Adjusted for the other covariates, non-whites reported, on average, lower satisfaction than whites, and patients with lo

• br Among the current available assays

  2022-05-13

  

  Among the current available assays, conventional Northern blotting and microarray analysis generally have insufficient sensi-tivity for miRNAs at low expression level [7,8]. Furthermore, both of them only provide a limited degree of qualitative results [9]. Small difference in low-abundant miRNA l

• e Never permanent night shifts f Family history of

  2022-05-10

  

  e Never permanent night shifts. f Family history of breast/prostate cancer. g Among parous women. h Among postmenopausal women. Table 2 Descriptive characteristics among controls by occupational exposure to alkylphenolic compounds. Breast cancer Prostate cancer Never exposed Ever

• br Fig e The proportions of included patients administered

  2022-05-09

  

  Fig. 2 e The proportions of included patients administered adjuvant systemic treatments. (A) CHT regimens in patients with luminal A subtype disease. (B) CHT regimens in patients with luminal B subtype disease. (C) ET period for all included patients. (D) ET regimens for all patients. (Color versi

• br ACCEPTED MANUSCRIPT br The current study was performed with

  2022-05-06

  

  ACCEPTED MANUSCRIPT The current study was performed with the goal of defining the prevalence of occult LN metastases discovered on combined endosonography during a single procedure performed with endobronchial ultrasound (EBUS) and endoscopic ultrasound (EUS) fine needle aspiration in the radio

• br Herein we developed a nanoplatform

  2022-05-04

  

  Herein, we developed a nanoplatform for simultaneous multimodal imaging and combined PDT and PTT by integrating CuS nanoparticles (PTT agents) and g-C3N4 QDs (PDT agents) on mesoporous silica-coated UCNPs, followed by modification with PEG and folic acid (FA). The design strategy of the system is

• br Our ROC analysis revealed

  2022-05-04

  

  Our ROC analysis revealed that a combination of H19, MEG3 and miR-675-5p able to discriminate controls and GC subjects with 88.87% sensitivity and 85% specificity. It has been demonstrated that due to the Parameter n ncRNAs gene expression MEG3 Low High Low High Low High Low

• br A br Particle size

  2022-05-04

  

  A Particle size (nm)  Zeta potential (mV)  efficiency Encapsulation 60 Fig. 3. Encapsulation efficiency of resveratrol liposomes. DNA-binding ability of liposomes enhanced with the increase of N/P weight ratios. CDOR5, CDOR10, CDOR20, CDOR100 and CDOR200 retarded plasmid DNA c

• br To analyze the transcriptome of serum cultured

  2022-05-04

  

  To analyze the transcriptome of serum-cultured cells, sphere-  cultured cells, LL clone AZD8931 and S clone cells, we performed Serial analysis of gene expression sequencing (SAGE-Seq). More than 20,000,000 tags were read per sample, and a total of 18,587 genes were detected in the analysis

• Scher HI Graf RP Schreiber

  2022-04-29

  

  [13] Scher HI, Graf RP, Schreiber NA, et al. Nuclear-specific AR-V7 protein localization is necessary to guide treatment selection in metastatic castration-resistant prostate cancer. Eur Urol 2017;71:874–82. [14] Scher HI, Lu D, Schreiber NA, et al. Association of AR-V7 on circu-lating tumor 13(S)-

• br Ludovini V Gori S

  2022-04-29

  

  68. Ludovini V, Gori S, Pistola L, et al. Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation. J Thorac Oncol 2008; 3:452-3. 69. Kerner GS, Schuuring E, Sietsma J, et al. Common and rare EGFR and KRAS mutations in a

113 records 4/8 page Previous Next 12345 Next 5 pages Last page